Iloprost treatment for refractory Raynaud's phenomenon in two infants

Dror S. Shouval*, Masza Mukamel, Francesco Zulian, Jacob Amir, Liora Harel

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Raynaud's phenomenon (RP) is rare in young children. We describe two infants with severe RP, manifesting as fingertip necrosis, who were resistant to conventional vasodilators and were treated successfully with iloprost, a prostacyclin analogue. The application of iloprost is safe and should be considered in children with threatening ischemic digits.

Original languageEnglish
Pages (from-to)S105-S107
JournalClinical and Experimental Rheumatology
Issue number3 SUPPL. 49
StatePublished - May 2008
Externally publishedYes


  • Children
  • Iloprost
  • Ischemic digits
  • Prostaglandin
  • Raynaud's phenomenon


Dive into the research topics of 'Iloprost treatment for refractory Raynaud's phenomenon in two infants'. Together they form a unique fingerprint.

Cite this